Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BerGenBio
Growth Score
30
CB Rank
161949
Heat Score
36
Save
Actions
BerGenBio is clinical-stage biopharma developing first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.
Founded
obfuscated
obfuscation
Public
Post-IPO Debt
Bergen
,
Hordaland
,
Norway
11-50
www.bergenbio.com
Biotechnology
Pharmaceutical
BerGenBio
Section: Technology
Actions